Cargando…
Is adjuvant chemotherapy necessary for early gastric cancer?
OBJECTIVE: To quantify the potential benefit of adjuvant chemotherapy (ACT) with respect to survival, and to identify factors for predicting prognoses in early gastric cancer patients. METHODS: Patients with pT1 gastric cancer (GC) who underwent radical resection with D2 lymphadenectomy were retrosp...
Autores principales: | Mei, Yu, Feng, Tienan, Yan, Min, Zhu, Zhenggang, Zhu, Zhenglun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088187/ https://www.ncbi.nlm.nih.gov/pubmed/34160167 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0636 |
Ejemplares similares
-
Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
por: Mei, Yu, et al.
Publicado: (2022) -
Nomograms Involving HER2 for Predicting Lymph Node Metastasis in Early Gastric Cancer
por: Mei, Yu, et al.
Publicado: (2021) -
Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020) -
Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
por: Shin, Hyun Beak, et al.
Publicado: (2017) -
Is adjuvant chemotherapy necessary in older patients with breast cancer?
por: Morita, Midori, et al.
Publicado: (2022)